Soon-to-be mums admit they feel “left in the dark” when it comes to being told about the possible implications of prenatal screening – tests which could lead them down a path where they have to make difficult decisions about their unborn child.
National AIDS Research Institute (NARI), Pune, is conducting a first phase of clinical trial of a newly developed HIV/AIDS vaccine. This ongoing trial is being done under the joint auspices of the National AIDS Control Organization (NACO), the Indian Council of Medical Research (ICMR) and the International AIDS Vaccine Initiative (IAVI).
A 26-year-old Egyptian man died of bird flu on Wednesday, the third member of his extended family to die of the virus, a World Health Organisation (WHO) report highlighted.
Breast Cancer Action (BCA) released a report today, in conjunction with a poster presentation at the San Antonio Breast Cancer Symposium, on the side effects of aromatase inhibitors (AIs). The report, “Side Effects Revealed: Women’s Experiences with Aromatase Inhibitors,” analyzes 612 women’s responses to an online survey of the drugs’ side effects.
Neurobiologists have discovered why the aging brain produces progressively fewer new nerve cells in its learning and memory center. The scientists said the finding, made in rodents, refutes current ideas on how long crucial “progenitor” stem cells persist in the aging brain.
Almost four in five Australians (78 percent) support mandatory fitness testing for school children to combat childhood obesity, according to a new public opinion poll by Research Australia.
Children at risk of contracting juvenile diabetes may soon be vaccinated against the disease by administering insulin through a nasal spray device if a Melbourne-based clinical trial proves successful.
The Indian Council of Medical Research (ICMR) study revealed that condoms designed to meet international sizes are too big for most Indian men.
At the American Society for Cell Biology 2006 conference, scientists will describe new research indicating that both yeast and cancer cells evolve chromosome duplications to work around lethal stresses.
Surgeons at the Methodist DeBakey Heart Center in Houston were among the first in the U.S. to implant a new vascular graft engineered to reduce the risk of blood clots in patients treated for peripheral arterial disease (PAD), which affects as many as 12 million Americans over the age of 50.